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Open field and emergence test activity was observed in three 
separate experiments using a total of 144 male and female albino rats. 
Subjects were injected with either propranolol (Experiment One), 
oxprenolol (Experiment Two), or atenolol (Experiment Three) in doses of 
5, 10 or 20mg/kg approximately 30 minutes prior to testing. The aim was 
to determine whether the drugs exerted behavioural effects on free 
responding, and whether such influences could be interpreted in terms of 
an anxiolytic action. Behavioural variables measured were walking, 
rearing, grooming, centering, cornering, transitions, half body emergence 
time and total body emergence time. Faecal boli were also counted at the 
end of each subject's observation time in the open field apparatus. 
Analyses of Variance revealed significant influences of 
propranolol on rearing, walking and cornering behaviour. Oxprenolol 
significantly affected rearing, transitions and emergence measures. 
Atenolol significantly affected rearing and half body emergence. It was 
concluded that, within the interpretative limitations of the behavioural 
measures used, an anxiolytic action could be postulated for propranolol 




Beta-adrenergic receptors in the sympathetic nervous system 
The sympathetic nervous system, as part of our autonomic nervous 
system, mediates stress-induced energy mobilization within the body. 
Sympathetic functions prepare the body for the increased level of motor 
activity involved in attack, defense or escape reactions to stress. 
Ahlquist (1948) noted that sympathetic nervous system receptors may be 
classified as a or S according to the response of various tissues to 




(vascular, bronchial and gastrointestinal smooth muscle) 
receptors. Alpha receptor stimulation leads to smooth muscle contraction 
in blood vessels, the uterus and iris (Gibson, 1974). Stimulation of S 
receptors leads to smooth muscle relaxation in the bronchi, intestine and 
uterus, along with an increase in the rate and force of cardiac 
contraction. 
Three known candidates for S receptor agonists within the sympath-
etic nervous system exist. These are dopamine, nor adrenaline and 
adrenaline. Adrenaline has both a and S-agonist effects and, although 
occurring in only small amounts in the brain, is the most potent physio-
logical S receptor agonist known. Nor adrenaline is primarily an a 
receptor agonist although it does serve as a S receptor agonist in the 
heart, for example. Another receptor for dopamine exists in the brain 
and dopamine makes a very poor S receptor agonist in the peripheral 
nervous system (Carlsson, 1975). 
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Of interest in this study is the effect of three drugs which block 
8 adreneregic receptors on some aspects of rat behaviour. 
The sympathetic nervous system and anxiety 
Both psychological and somatic symptoms occur when anxiety is 
experienced. For example, symptoms of tension, fear, difficulty in 
concentrating or apprehension may occur in combination with tachycardia, 
palpitations, tremour or gastrointestinal upset. Physiological changes 
include an increase in pulse rate, systolic blood pressure, muscle 
activity and respiratory rate, a decrease in salivation and finger pulse 
volume, perspiration (diaphoresis) and excessive pupil dilation (Hayes 
and Schulz, 1983). These changes result mainly from 8-sympathetic over-
activity. Such overactivity may form a chemical base to the suggestion 
made by James (1890) that somatic symptoms can reinforce anxiety 
(Carruthers, 1975). The James-Lange hypothesis suggests that the 
experience of anxiety is secondary to the perception of bodily changes. 
That is, through a positive feedback loop there is cerebral recognition 
of somatic symptoms of sympathetic activity and their association .with 
previous experiences of anxiety (James, 1984). 
There is a class of drugs, known as Sblockers, which inhibit 8 
adrenergic activity. As such they disrupt any indications of emotionality 
mediated by 8 receptors. This had led to their application to the treat-
ment of anxiety in a clinical setting. Their usefulness in this area 
remains unclear. Benzodiazepines are currently the drugs of choice in 
the treatment of anxiety. These appear to be effective in decreasing 
both psychological and somatic symptoms. Since anxiety disorders tend to 
be episodic, optimal response to benzodiazepines occurs when therapy is 
initiated during exacerbation periods and administration is restricted to 
brief intervals of 2-3 weeks. There is little evidence to suggest that 
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such drugs continue to be effective for longer periods of time (Hayes and 
Schulz, 1983). High doses administered for some time are also associated 
with the risk of dependence. 
An alternative to the benzodiazepines is the barbiturate class of 
drugs. Their use also carries with it the risk of dependence. 
Because of these adverse consequences there is current interest in 
other methods of anxiety treatment. 
blockers. 
One such alternative may the be 8 
8 blocker uses 
Beta blocking drugs were initially used to treat cardiac 
complaints associated with sympathetic overactivity. Today such uses 
include the treatment of sinus tachycardia, 
obstructive cardiomyopathy and angina pectoris. 
cardiac arrhythmias, 
Granville-Grossman and Turner (1966) were the first researchers to 
investigate the effects of 8 blockers on anxiety. Only autonomically 
mediated symptoms such as palpitations, sweating and diarrhoea were 
significantly affected. Physical symptoms, non autonomically mediated, 
such as headache, were not affected. Neither were mental symptoms of 
worry, tension and fear. Beta blocker action thus appears to be 
selective. While a series of studies have shown the drugs to be useful 
in treating clinical anxiety their effectiveness seems to be limited in 
the treatment of anxiety induced in normal subjects. Lader (1977) 
suggested why this might be. The bodily symptoms of anxiety in normal 
subjects are mild and explicable. Any reduction due to 8 blockade would 
be unimportant. Compounds which influence the central, cognitive aspects 
should be more effective. Beta blockers should be of help to normal 
subjects experiencing the irrational feelings associated with phobic 
stimuli and the heightened anxiety experienced before examinations, in 
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stage fright and public speaking. They should also be effective in 
treating clinically anxious patients with somatic symptoms. In both 
these groups peripherally mediated, irrational somatic symptoms are 
dominant. In psychically anxious patients, where many of the 
physiological changes are not disturbing and subjective symptoms are 
dominant, drugs which affect the cognitive aspects of anxiety directly 
should be more effective. 
Various other uses for the 8-blockers have been suggested. Animal 
experiments have shown that the 8 blocker propranolol inhibits brain 
binding of morphine in mice (De Feudis and Grosz, 1972) and modifies some 
behavioural changes induced by morphine in rats (Block and Grosz, 1974). 
From these have come the suggestion that the drug could be of use in the 
treatment of opioid dependence. 
largely been negative however. 
Findings with respect to humans have 
A use for 8 blockers has been implicated in the treatment of 
Parkinsonism, essential tremour and lithium-induced tremour. Beta 
blockers decrease the adrenaline-induced increase in Parkinsonian tremour 
amplitude. Overall, reports on the effectiveness of the drugs in 
treating this particular disorder are inconsistent (Agnoli, Cerone, 
Ruggieri, Cappenberg and Aloisi, 1977), as are those associated with 
lithium induced tremour (Tyrer, 1981). 
There have been some reports of successful treatment of psychoses 
using 8 blockers. For example, Atsmon (1972) reported that 600mg of 
propranolol per day removed the abdominal symptoms and psychosis of a 
woman diagnosed as suffering from porphyria associated with a symptomatic 
psychosis. The symptoms reappeared upon withdrawal of the drug while 
readministration removed them again. 
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S blocker chemical structure 
The S blockers are characterised by a catecholamine-like chemical 
structure. It is this which allows for reversible blocking of S -
adrenergic receptors in the sympathetic nervous system. 
The drugs used in the present study were propranolol C®rnderal), 









NHCH 3 00 ca3 
aromLc nucleus with affinity for S receptors 
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Properties of the 8 blockers 
All 8 blockers used clinically are known to block 8
1 
receptors and 
most therapeutic effects are based on this blockade. Non selective 8 
blockers block 8
2 
adrenoceptors as well. Only in the treatment of 
glaucoma and certain forms of tremour is 8
2 
blockade known to be the 
basis of the therapeutic effect (van Zwieten and Timmermans, 1983). 
Atenolol is a cardioselective 8 blocker, it does not show central 8 
blocking activity. Both propranolol and oxprenolol are non selective. 
Propranolol and oxprenolol, when injected intracerebrally or 
intracerebroventricularly, decrease cell membrane permeability for ions 
such as sodium, potassium and calcium. This membrane stabilizing or 
local anesthetic effect is not exhibited by atenolol. 
Some 8 blockers, as well as preventing the binding of catechol-
amines to adrenergic receptors, cause mild stimulation of the receptors. 
Such intrinsic sympathomimetic activity is shown by oxprenolol and 
appears to be dose dependent (Saxena and Forsyth, 1976). The 8 blocking 
drugs differ in their ability to cross the blood-brain barrier, depending 
on the plasma concentration of the free drug and its lipophilic 
structure. Lipophilic agents such as propranolol pass easily into the 
central nervous system. Oxprenolol, being less lipophilic, crosses less 
readily and atenolol, which is hydrophilic, crosses only poorly. The 
theoretical distribution of a blocker in the plasma and central nervous 
system follows the pattern 






Bound drug in 
brain/CSF 
(Cruikshank, Neil-Dwyer, Bartlett 
& McAinsh 1982) 
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Distribution of lipophilic 8 blockers within the blood/cerebrospinal 
fluid/brain compartments occurs within minutes. Equilibration of 
atenolol is considerably slower (Cruikshank et al., 1982). Finally, the 
different 8 blockers vary in the way they are metabolised. Lipophilic 
compounds (eg. propranolol, oxprenolol) are extensively metabolised in 
the liver. Hydrophilic compounds are excreted largely unchanged by the 
kidneys (Johnsson and Regardh, 1976). Most 8 blockers have a short half 
life, for example atenolol's plasma half life is 6-9 hours after a single 
dose while propranolol's is 2-3 hours (Kelly, 1978). 
A variety of effects of 8 blockers in the periphery and central 
nervous system have been noted. Explanation of these characteristics is 
made difficult by the varying properties of the different drugs. This is 
seen at present in the sometimes inconclusive or contradictory findings 
in antianxiety research. 
B blocker anxiolytic mechanisms of action 
Three possible ways in which the 8 blockers could exert an anti-
anxiety effect have been suggested. 
1. S blockers act directly and specifically on CNS B adrenergic receptors 
8 adrenergic receptors have been identified in the CNS (eg. Davis and 
Lefkowitz, 1976; Margules, 1971). The CNS is known to contain extensive 
adrenergic pathways linking different brain areas, including those 
involved in fight/flight functions. The locus coeruleus, for example, 
found in the brain stem, contains many adrenergic neurons and projects 
widely to the cerebral cortex. It is thought to play a key role in the 
genesis of anxiety (Lader, 1974). 
Evidence for a direct (although not necessarily specific) mode of 
action comes from the observation that some of the central effects seen 
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after systemic S blocker administration are mimiced after direct appli-
cation to or into the brain. 
For those drugs which readily cross the blood brain barrier a 
direct specific central mechanism of action cannot be ruled out. Drugs 
which penetrate the CNS to a lesser degree may act in other ways, unless 
given in large doses. 
2. S blockers act directly on the CNS independently of a specific adren-
ergic receptor 
It may be that the antianxiety effects seen after administration 
are due to properties of the drugs other than S receptor blockade. For 
example, Speiser and Weinstock (1973) demonstrated that both dl-(0.2 and 
0.5 mg/kg) and d-(0.5-1.0 mg/kg) propranolol produce sedation in 
isolation-induced hyperactive mice. The a-isomer lacks significant S-
blocking properties. The sedative effect observed may be attributable to 
another property of the drug, such as its central cell membrane 
stabilizing effect, known to occur in both isomers. Bainbridge and 
Greenwood (1971) found similar results with the propranolol isomers and 
their tranquillizing effect in rats conditioned to expect electric shock 
or made hyper-reactive through septal lesions. Whether these animal 
studies can be related to the mechanism of drug action in humans is 
questionable since the doses used were much higher than those in 
therapeutic practice. There is some evidence for such a mechanism 
operating in human subjects eg. Farhoumand, Harrison, Pare, Turner and 
Wynn (1979), with respect to oxprenolol. 
3. 8 blockers act on peripheral receptor sites. Neural and/or homoral 
feedback results in the central awareness of anxiety reduction 
Estler and Ammon (1969) found no central effect of the (hydro-
philic) S blocker practolol in man. Bonn and Turner (1971) showed 
however that practolol is able to relieve anxiety in human subjects. 
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Information about peripheral effects of the drug must have reached the 
CNS in such a case. There is evidence for this type of feedback 
mechanism. For example, it is known that a reduction in heart rate 
decreases, indirectly, subjective anxiety. Also, the activity of some 
CNS structures can be changed by objective changes in neuro-humoral feed-
back due to altered levels of peripheral autonomic activity. For 





pressure variations, which in turn alter levels of central activity. 
Some areas of the brain are located outside the blood-brain barrier. 
These include the area postrema, subfornical organ and the subcommisural 
organ. Any 
peripheral. 
S blocking action on these structures is, by definition, 
It seems that a single mechanism of S blocker action is not 
exclusively responsible for the ultimate antianxiety effects observed. 
Which mechanism is operational depends on the species, behaviour model 
being studied, the drug employed and the initial level of activity of the 
particular function being studied (Koella, 1977). With respect to the 
anxiolytic properties of blockers the evidence, although not 
unequivocal, favours a peripheral mechanism in human subjects. In animal 
studies anxiety can be measured only indirectly. From these studies 
there is majority support, although once again not unequivocal, for a 
nonspecific central action. 
Anxiolytic effects of the $-blockers: Animal studies 
Experiments on animals have traditionally introduced stressors 
into the environment in order to induce an emotion paralleling human 
anxiety. Such stressors include prolonged isolation, conflict tasks, 
drug and surgical manipulations. It is unclear, however, whether or not 
stress-induced states in animals relate to anxiety in humans. Lader 
(1974) likens the gross alterations in behaviour seen in the 
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"experimental neuroses" more to the acute traumatic neurotic syndrome 
(eg. following major disasters such as earthquakes) than to anxiety 
s·tates. Thus, more subtle animal models must be used. In the 
experiments described in this thesis exposure to a novel environment 
provides the source of anxiety. 
Of the three drugs administered in this study propranolol has been 
investigated most extensively within the experimental neurosis paradigm. 
Some researchers have found an apparent antianxiety effect with this 
drug, others have found none. Robichaud, Sledge, Hefner and Goldberg 
(1973), using the experimentally induced conflict task of Geller and 
Seifter (1960) obtained what they described as a suppression of behaviour 
in male Long Evans hooded rats. The rats, maintained at 70% of their 
mature body weight, were able to bar press for food accompanied by 
electric shock. Propranolol (Smg/kg i.p.) had no effect on this suppres-
sion. It also had no effect on the avoidance performance of male albino 
mice (C.F.W. stain) partially trained to avoid electric shocks in the 
shuttle box. Both of these experimental models are predictive of 
clinical activity for several classes of antianxiety agents including the 
benzodiazepines. When administered in combination with chlordiazepoxide 
propranolol had no influence on the effect of the tranquillizer in either 
procedure. It may be that the dose of propranolol used in this 
experiment was not high enough to bring about a behavioural change, 
although Sepinwall, Grodsky, Sullivan and Cook (1973) found little effect 
of doses from 2.5 to 80mg/kg adminstered orally. These experimenters 
used a similar lever pressing conflict procedure on male Charles River 
albino rats. Typically with this procedure a dose related increase in 
punished responding is seen, frequently several 100% above control 
levels. In this investigation the 26% increase at a dose of 20mg/kg was 
the only one which reached statistical significance. 
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These results contrast with those of Bainbridge and Greenwood 
(1971) who reported an apparent tranquillizing effect of 10 and 20mg/kg 
p.o. propranolol on male albino rats (Alderly Park strain 1) conditioned 
to expect an electric shock. A decrease in the hyperirritability of 
septally lesioned rats was also seen after propranolol administration. 
The authors saw both conditions as plausible models of clinical anxiety. 
Rather than a general depression of behaviour the tranquillizing effect 
was interpeted as an antianxiety effect since dl-propranolol caused a 
significant increase in preening behaviour immediately following CS 
presentation. Propranolol had its effect in common with four represent-
ative central nervous system depressants also tested; chlorpromazine, 
haloperidol, chlordiazepoxide and phenobarbitone. D-propranolol had no 
such effect. A second series of experiments involving dl-propranolol and 
phenobarbitone showed that both drugs significantly decreased freezing 
and increased exploratory behaviour. These effects were interpreted as 
resulting from behavioural disinhibition and a decrease in tension/fear. 
Weinstock and Speiser (1973) found that both d- and dl-propranolol 
(0.2-0.Smg/kg) decreased isolation-induced hyperactivity, sniffing and 
rearing in male albino rats (Wistar strain) in the open field. 
Practolol, another S blocker, was similarly effective. The doses used 
were without effect on control subjects housed 4-6 per cage. 20mg/kg dl-
propranolol was necessary to reduce the activity of the group-housed 
rats. Parallel results have been found in humans. Propranolol has been 
shown to sedate psychotic patients but, even at relatively high doses, 
does not show any significant central effects on normal human subjects 
(Lader and Tyrer, 1972). Archer (1973), for example, interpreted 
decreased locomotor activity in terms of increased rather than decreased 
anxiety. This makes the interpretation of these results unclear. It can 
be concluded, therefore, that with respect to propranolol and experiments 
which attempt to manipulate animal anxiety levels findings are 
inconclusive and their validity has been questioned. 
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Hughes (1981) investigated the effect of oxprenolol (10 and 
20mg/kg i.p.) on emergence latency, novelty preference, rearing and 
ambulation in an exploration box. Both doses decreased emergence latency 
- a possible antianxiety effect. Because there was no effect observed on 
centrally mediated novelty preference and rearing it was concluded that a 
peripheral anxiolytic effect was probably operational. Centrally acting 
diazepam was also tested. Rearing and novelty preference, as well as 
emergence latency, were decreased in a dose related manner. Subjects of 
this experiment were both male and female hooded rats (randomly derived 
strain). 
Oxprenolol (l00mg/kg p.o.) also has shown an antianxiety effect on 
the development of hyperthermia in a shock enclosure. Noble and Delini-
Stula (1976) subjected male albino Wistar rats to inescapable shocks once 
a day for five days. Exploratory behaviour (head dipping in a hole 
board), suppressed by previous exposure to shocks, was uninfluenced by 
oxprenolol. Within the oxprenolol treated group grooming decreased from 
the first day of the trial onwards. Tinbergen (1952) saw grooming as a 
manifestation of fear while 0'Kelly (1940) saw it as a non adjustive 
reaction to stress. Hyperthermia has been interpreted as a somatic 
manifestation of emotional disturbance (Delini-Stula and Morpurgo, 1970; 
Miller, 1969). 
Thus the small amount of research involving oxprenolol does appear 
to support an antianxiety effect. 
remains largely uninvestigated directly. 
Atenolol's role in animal anxiety 
Weinstock and Weiss (1980) 
investigated the effects of$ blockers including dl-propranolol, d-
propranolol and atenolol on male mice (Sabra Hebrew University strain). 
Insofar as aggression may be one reaction to anxiety this investigation 
looked at the effect of the S blockers on anxiety. While dl-propranolol 
showed a significant antiaggressive effect in doses less than 5mg/kg, 
neither atenolol nor d-propranolol were active, even at doses up to 
20mg/kg. 
13 
Measures of emotionality 
How is it possible to measure anxiety in animal subjects? 
Behaviours which have been interpreted as being influenced by anxiety 
include freezing, rearing, grooming, active escape, ambulation, 
defecation and emergence. At their most specific these behaviours might 
be seen to reflect an underlying emotionality construct. To see this 
emotionality as anything more specific involves the danger of anthropo-
morphism. Labelling a behaviour as reflecting a particular emotion poses 
the question - how can the emotions be differentiated? Both behaviourally 
and physiologically there is little to discriminate between similar 
intensities of differing emotions. 
Emotionality describes aspects of the generally excited and upset 
condition of animals faced with unfamiliar situations (Doyle and Yule, 
1959). Measuring the relative emotionality of animal subjects typically 
involves the open field environment. In the open field an animal is 
faced with a large, empty, spatially bounded, illuminated area. Since to 
a cage reared, experimentally naive animal the situation is unfamiliar, 
its novelty may be presumed to provoke a fear or anxiety type of reaction 
(Doyle and Yule, 1959). Ivinskis (1970) has noted that it is usually 
difficult to estimate the validity of open field measures, mainly because 
there are no external validation criteria. 
The two most commonly used measures of emotionality are ambulation 
and defecation. Hall (1934, 1936) first established the validity of 
defecation scores as a measure of open field emotionality. Subsequent 
researchers have replicated his findings (eg. Ivinskis, 1970; Whimbey and 
Denenberg, 1967). High defecation rates correlate positively with 
emotionality. As well as having proven validity, the reliability of this 
measure has been shown to be acceptable in several species. 
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Like defecation, ambulation shows acceptable reliability across 
species. A negative relationship between the two measures has 
consistently been shown within the literature (Walsh and Cummins, 1976). 
This suggests that ambulation would increase with decreased emotionality. 
However, both increases and decreases have been observed over time. It 
has been suggested that ambulation could provide a factorially complex 
score, indicative of an emotionality factor and an exploration factor. 
Thus, rather than reflecting a decrease in emotionality, ambulation could 
reflect an increase in exploratory drive. The relationship between 
exploration itself and emotionality is unclear. High levels of emotion-
ality may inhibit exploration as is seen in its extreme in the freezing 
response. Here the animal "adopts a compact crouching posture and 
remains completely motionless, even nose twitching being absent" (Doyle 
and Yule, 1959, p.18). Alternatively, emotionally arousing stimuli may 
induce exploration if, as suggested by Glanzer (1953), the biological 
function of exploration is to reduce one's fear of the environment. The 
interpretation of an ambulation measure is difficult, especially where 
only one trial is given and defecation score information is not 
considered (Walsh and Cummins, 1976). Although providing an apparently 
reliable measure of emotionality, ambulation's validity has been 
questioned. Ivinskis (1970), on the basis of three criteria; 1) inter-
trial decrease of scores across four days; 2) effects of prior open field 
testing to decrease scores, and 3) effects of alterations in ambient 
auditory and visual stimulation, concluded that ambulation was an 
invalid measure of emotionality. However, the adequacy of these criteria 
would seem to be debatable. Ivinskis concluded that only the third was 
satisfactory. 
Like ambulation, rearing has at times been taken as a negative 
indicator of emotionality (Ader, 1965; Gray, Levine and Broadhurst, 
1965). If this is so, then a negative relationship between defecation 
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and rearing should occur over retests. Ivinskis (1970) failed to find 
such a relationship. If rearing was considered to measure exploratory 
behaviour (Pare, 1964) Ivinskis suggested that the decrease in rearing 
scores over retests could be explained more satisfactorily. Results of 
this experiment agreed with those of Montgomery (1953) who found that 
exploration decreased over time with repeated exposure to the same 
environment. 
Ambulation and emergence latency are negatively correlated in the 
rat. Ivinskis (1970) found latency to be a valid measure of emotionality. 
According to Beveridge, Meatchem and Kirk (1981), although a number of 
tests exist (eg. the open field), the emergence test is generally thought 
to best represent an adequate measure of the varying degrees of emotion-
ality in laboratory rodents. Emergence latency increases with increased 
emotionality and decreases with decreased emotionality. Time taken to 
emerge also shows some loading on the exploratory behaviour factor. 
Grooming displayed in an unfamiliar environment is generally 
regarded as a sign of fear (Tinbergen, 1952). Some authors disagree. 
For example Bolles (1960) suggested that, rather than being a reaction to 
novelty or an anxiety/fear provoking situation, much of the time grooming 
occurs because a sequence of eating, drinking or exploratory behaviour 
has just been concluded. This grooming is highly stereotyped - licking 
the fur, scratching with a hind leg, and washing the face. It may be 
regarded as displacement activity differing from other types of grooming 
such as those occurring in association with sexual and maternal 
behaviour. Doyle and Yule (1959) found no support for grooming as a 
displacement reaction in the open field. Also, the grooming behaviour of 
the male albino rats used as subjects was not correlated with emotion-
ality as measured by, for example, defecation. Walsh and Cummins (1976) 
noted that grooming has been found to be of relatively low reliability. 
It may be this which accounts for the inconsistent findings in the 
literature. 
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In the open field rats are reluctant to leave the wall or corners 
and approach the centre. Occupancy of the periphery, either near walls 
(Valle, 1970) or in corners (Morrison and Thatcher,1969) has therefore 
been used as a measure of timidity. 
Aims of the present study 
The main aim of this study was to determine whether three of the 
beta-adrenoceptor blocking drugs exert any behavioural effects in a free 
responding situation and whether such effects could be the result of an 
anxiolytic action. It has been suggested that observation of 
unconditioned behaviour, in the emergence test and open field for 
example, could provide a useful way of highlighting subtle drug effects 
which might be obscured by more rigorous experimental 
(Maxwell, 1968). 
procedures 
A further aim was to determine whether any sex differences in 
responsiveness to the drugs exist. Many past investigations used only 





Forty-two randomly derived Wistar strain albino rats, 13 male 
(mean age 114 days; range 111-117 days) and 29 female (mean age 112 days; 
range 109-115 days) from the Otago Medical School were used. Five males 
(age 94 days) and one female (age 130 days) from the University of 
Canterbury colony were added to make the total number of test animals 48. 
Housing was in group cages of three or four same-sex animals. The rats 
had been handled regularly from birth. An optimal temperature of 24±1°c 
was aimed for in the colony room. Due to inconsistencies within the 
heating system variation of ±5°c occurred. A reversed 12 hour light-
dark cycle was in operation, the dark phase lasting from 6 am to 6 pm. A 
noise level of 52-70dB was characteristic of the colony room. All animals 
received ad lib food and water up until the time of individual testing. 
Testing was conducted between 1-4.30 pm. 
Apparatus 
Subjects were tested for emergence latency and behaviour in the 
open field. The emergence test apparatus consisted of a darkened wooden 
box separated by a sliding partition from a larger, illuminated box. The 
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darkened box, lxwxh = 210xl75x310mm, had a hinged, semi-transparent lid 
through which each experimental subject was introduced to the test 
apparatus. Removal of the partition revealed a lOOxlOOmm opening into 
the illuminated area. Walls of the illuminated area were wooden, painted 
white. The floor was made of translucent white perspex. Lighting of 375 
lux was provided by a source situated beneath the perspex. A wire mesh 
lid covered the area. This was painted white in order to reflect light 
back into the enclosed space, 
525x525x335mm. 
This space had dimensions lxwxh = 
The open field apparatus had clear perspex walls 300mm high. The 
base, 600x600mm, was black perspex, being divided by white lines into 16 
150xl50mm numbered squares. 
Within the experimental room white noise was maintained at a level 
of 60dB. Illumination was 320 lux. A beeper, set to sound at five 
second intervals, was on continuously. 
Procedure 
Animals were randomly assigned to one saline and three drug groups 
in the ratios 
saline Smg/kg 
males 5 4 







Subjects were tested in series of three, six animals being tested per 
day. In the colony room rats were transferred by the experimenter from 
their home cages to holding cages, either alone or with age mates from 
the same home cage if these were also being tested. The holding cages 
were then carried to the experimental room approximately Sm away. At 15 
minute intervals a rat was removed from its holding cage, injected (i.p.) 
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with either isotonic saline (0.lcc/kg) or propranolol, 5, 10 or 20mg/kg. 
Because only the 5mg/kg concentration was available volume changes were 
required for different doses. 
5mg/kg - lee/kg 
l0mg/kg - 2cc/kg 
20mg/kg - 4cc/kg 
The rat was then returned to its holding cage. Approximately 30 minutes 
after injection (range 30-36 minutes) the subject was placed by the 
experimenter in the darkened box of the emergence test apparatus 2m away. 
Beveridge et al. (1981), using confinement times of 15, 30 and 60 sec, 
found a significant linear relationship between emergence latency and 
confinement time. Increased length of confinement in the darkened box 
was associated with longer latencies. For this reason a confinement time 
of 15 sec was chosen for this experiment. After 15 seconds the wooden 
partition was removed and time taken for the rat to move into the 
illuminated area was recorded. The experimenter observed emergence 
through the wire mesh. Two emergence measures were recorded for each 
animal, ie., 
(a) Time taken for all parts of a forward facing rat, up to and 
including the point halfway between the front and rear legs (as judged by 
the experimenter) to emerge. 
(b) Time taken for all parts of a forward facing rat, up to and 
including the rear legs, to emerge. 
If the subject had not emerged after 5 minutes timing ceased and latency 
was recorded as 300 seconds. 
Upon completion of the emergence test the rat was picked up by the 
experimenter and placed in the centre of the open field apparatus. The 
centre was chosen because of the tendency noted by Satinder (1969) of 
rats to remain on the side of the field where they were originally 
placed. Each subject was observed for 10 minutes. Every five seconds, 
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as indicated by the automatic beeper, it was noted which square the 
animal was predominantly in. Also noted were 
(a) rearing behaviour, defined as the rat standing, either 
supported or unsupported, on its hind legs 
(b) walking, either within or between squares 
(c) grooming, defined as preening the body with either the mouth 
or leg(s). 
At the end of each trial faecal boli were removed and counted. Both the 
inside of the open field and the darkened box of the emergence test 
apparatus were thoroughly washed with a solution of "Hibitane" 
disinfectant/masker. It may have been unnecessary to wash the darkened 
box since Beveridge et al. found no specific effect of conspecific odour 
on emergence latency when confinement time was 15 seconds. 
significant effect was found with 60 second latency. 
However, a 
Total occurrences of each behaviour (walking, rearing, grooming) 
recorded with successive 200 sec intervals of the 10 minute open field 
test were determined for each rat. From records of squares occupied 
movement from one square to another in adjacent 5 sec intervals was 
recorded as a 'transition'. Total numbers of transitions in successive 
200 sec intervals were calculated from these. The number of recordings 
during which the subject occupied corner squares (1, 4, 13 or 16) or 
centre squares (6, 7, 10 or 11) were also calculated for each 200 sec 
interval. 
RESULTS AND DISCUSSION 
For each of the behavioural measures (walking, rearing, grooming, 
centre squares, corner squares, transitions, half body emergence, total 
body emergence) separate 2x4 Analyses of Variance were used to evaluate 
the effects of the 4 doses (saline, 5, 10 and 20mg/kg drug) for the 2 
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sexes. Where significant dose or interaction effects occurred individual 
group means were compared by post-hoc t-tests. For each t-test MS errors 
comprised the estimate of variance (df=40). Eyeballing the raw data 
suggested that analysis of the faecal boli measure would provide little 
useful information. This was because the data showed high variability 
between and within treatment groups. Results of the statistical analyses 
are summarised in Appendix A. 
Walking. Neither main effect was significant at the .05 level but 
a significant sex-dose interaction occurred (illustrated in Figure l; 
FA
8
(3,40) = 5.56, p<.01). For males there were no significant differences 
in mean walking scores between the different drug doses. Drugged animals 
showed significantly higher mean walking scores than saline controls 
(p<.01 (5mg/kg), p<.01 (lOmg/kg), p<.05 (20mg/kg)). Propranolol had the 
opposite effect on females. The mean walking scores of drugged animals 
were less than that of the saline group although onl}i the 20mg/kg rats 
showed a decrease which was significant (p<.01). 
The current results disagree with the U-shaped dose response curve 
obtained by Engel and Liljequist (1976) who investigated the effect of 
dl-propranolol on ethanol induced locomotor stimulation in female mice. 
Maximum reduction of induced locomotor stimulation occurred at doses of 
0.5-2mg/kg. The reduction disappeared with doses greater than lOmg/kg. 
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Figure 1 
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Rearing. Figure 2 illustrates both the significant sex main 
effect (FA(l,40)=5.67, p<.05) and the significant sex-dose interaction 
(FAB(3,40)=3.14, p<.05). Propranolol did not affect the rearing scores 
of the males, all comparisons were non significant. Female rats injected 
with 20mg/kg propranolol showed mean rearing scores which were signif-
icantly less than those of females in the saline, 5mg/kg and lOmg/kg 
groups. The otherwise nonsignificant changes in rearing rates between 
different groups were similar to results reported by Weinstock and 
Speiser (1973). Doses less than 20mg/kg were ineffective in decreasing 
the rearing of group housed control male rats. The aim of the experiment 
was to investigate the effect of propranolol on isolation induced hyper-
activity. 
The significant sex difference in rearing in the present 
experiment saw females with a greater average rearing score. The mean 
rearing score for females was 21.09 while for males it was 14.51. 
Hitchcock (1925) found that female albino rats are usually more active 
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than males. The significant sex difference in the present experiment is 
in agreement with those findings. It is also in agreement with Hughes 
(1972) who found, more specifically, that rearing scores for female 
albino rats are greater than those of males. 
Figure 2 
Propranolol dose-sex interaction effect on rearing scores 
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Grooming. Both main effects and the interaction effect were non 
significant. Searle (1983) also found no effect of propranolol on the 
grooming behaviour of rats in the open field (in the absence of a noxious 
stimulus). The tendency in the current results was towards a decrease in 
grooming behaviour with increased dose for both males and females. 
Transitions. All effects were non significant. Results were 
similar to those of Ksiazek and Kleinrok (1974) who reported no 
significant dose effect on transitions using 0.4, 1.0 and 2.0 µmole 
propranolol. At these dose levels any antianxiety effect is being 
confounded by a toxicity effect. The authors reported that at a dose of 
2.0 µmole 4 out of ten subjects died. 
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Corners. The sex-dose interaction effect was significant for this 
variable (FAB(3,40)=3.24, p<.05). The relationship is represented by 
Figure 3. Both main effects were non significant. For females the 
20mg/kg group showed a significant increase in cornering behaviour in 
comparison to the Smg/kg group. All other comprisons were non 
significant. Drugged males showed a decrease in cornering behaviour in 
comparison to the male saline group. Only the 20mg/kg group showed a 
decrease which was significant. 
Figure 3 
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Centres. Neither main effect, nor the interaction effect were 
significant. Centre and cornering behaviours were mutually exclusive in 
this experiment. Reflecting this, males tended to be found more in the 
centre of the open field with increasing drug dose while females tended 
to be there less. 
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Half body emergence. Although neither the main effects nor the 
interaction effect were significant a U shaped dose response relationship 
was observed for the half body emergency measure. Emergence latency was 
lowest at a dose of 5mg/kg propranolol. 
Total body emergence. All effects were non significant. For males 
the U shaped dose response curve observed in the half body emergence 
measure remained. Non significance of the gender main effect in the 
emergence test was also found by Beveridge et al. (1981). 
To summarise the results of Experiment One, 20mg/kg propranolol 
significantly decreased the rearing and walking of female rats in 
comparison to control subjects. This group also showed significantly 
increased cornering behaviour in comparison to the 5mg/kg female group. 
Unless some property of propranolol itself is increasing emotionality 
this suggests a sedative effect. The transitions measure provides a 
useful indicator of activity since increase emotionality has been related 
to decreased activity (Ader, 1965; Walsh and Cummins, 1976). Although 
insignificant the trend was towards decreased transition scores with 
increasing drug doses for females, again suggesting sedation (~ = 65 
(saline), 62.75 (5mg/kg), 63.86 (lOmg/kg) and 50.75 (20mg/kg)). 
Bainbridge and Greenwood (1971), for example, noted such a sedating or 
tranquillizing effect of 10 and 20mg/kg propranolol on male albino rats 
conditioned to expect electric shock. This sedation was interpreted as 
an antianxiety effect because an increase in grooming behaviour followed 
conditioned stimulus presentation. The results for the grooming measure 
in the present experiment were insignificant so such a conclusion cannot 
be drawn. Alternatively the significant results for 20mg/kg females 
could indicate a reduction in exploratory drive by propranolol. 
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Significant results for males occurred with the walking measure. 
Drugged males had mean walking scores significantly greater than 
controls. If ambulation is interpreted as increasing with decreasing 
emotionality it would be possible to say that propranolol reduces 
emotionality in male rats. Some support for this interpretation comes 
from the significant decrease in cornering behaviour, an indicator of 
timidity, of the 20mg/kg male group in comparison to the saline group. 
However, there are alternative interpretations of the walking measure 
(increased exploratory drive or general activity) and, as suggested by 
Walsh and Cummins (1976), in the absence of validation from other 
measures such as defecation, firm conclusions cannot be drawn. 
For grooming, transitions, centres, half body emergence and total 
body emergence the 
insignificant. 





Forty-eight albino rats, randomly derived Wistar strain, 18 males 
(mean age 120 days; range 117-124) and 30 females (mean age 119 days; 
range 115-123) from the Otago Medical School colony were used. These 
animals were reared and maintained under identical conditions to those of 
Experiment One. 
Apparatus 
The same emergence test and open field apparatus described in 
Experiment One were used. 
Procedure 
Both sexes were randomly assigned to one saline and three drug 
conditions in the same ratios as Experiment One. The experimental 
procedure followed exactly that of Experiment One with the exception of 
drug administration. Animals were injected (lee/kg i.p.) with isotonic 
saline or oxprenolol (5, 10 or 20 mg/kg). 
27 
28 
RESULTS AND DISCUSSION 
As in Experiment One, 2x4 Analyses of Variance followed by t-tests 
were used to evaluate the data. Results of the statistical analyses are 
summarised in Appendix B. Bali measures were again not analysed due to 
high variability between and within treatment groups. 
Walking. Neither main effect was significant. The sex-dose 
interaction was also insignificant. The results are similar to those of 
Hughes (1981) and Noble and Delini-Stula (1976). Hughes (1981) found 
that oxprenolol (10 and 20mg/kg i.p.) had no effect on the ambulation of 
male and female hooded rats in an exploration box. Noble and Delini-
Stula (1976) found that oxprenolol (lOOmg/kg p.o.) had no effect on 
exploratory behaviour which had been suppressed by previous exposure to 
inescapable electric shock. This experiment involved male Wistar rats 
.subjected to repeated measures over 5 days. 
Rearing. There was a significant sex main effect (FA(l,40)= 5.99, 
p<.05) as well as a significant dose main effect (FB(3,40)=4.36, p<.01) 
on rearing behaviour. Figure 4 shows the relationship between dose of 
oxprenolol and rearing. Saline treated rats showed significantly greater 
mean rearing scores than any of the oxprenolol treated groups (p<.05 
(5mg/kg), p<.05 (lOmg/kg), p<.01 (20mg/kg)). All other comparisons were 
non significant. The significant dose main effect contrasts with the 
findings of Hughes (1981). In that investigation oxprenolol (10 and 20 
mg/kg i.p.) had no effect on the rearing behaviour of male and female 
hooded rats in comparison to saline controls. 
In the present experiment the significant sex difference favoured 









Oxprenolol dose main effect upon rearing scores 
5 mg/kg 10 mg/kg 
DOSE 
20 mg/kg 
Grooming. There were no significant effects on this variable. 
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Transitions. For this variable neither the dose nor the sex main 
effect was significant. The interaction effect (outlined in Figure 5) 
was significant (FA
8
(3,40)=2.88, p<.05). The male subjects in the 
20mg/kg group showed a decrease in mean transition scores which was 
significantly less than that of the saline and 5mg/kg groups. Females in 
the 20mg/kg group showed an increase which was significantly greater than 




















Oxprenolol dose-sex interaction effect on transition scores 
saline 
Corners. 





All effects were non significant. Although reaching a 
significance level of 0.10, the dose main effect just failed to reach an a 
level of .OS. Directional similarities between oxprenolol and propranolol 
were apparent in the dose response curve for females. 
Centres. Neither the main effects nor the interaction effect were 
significant. Once again there were directional similarities in the dose 
response curves of oxprenolol and propranolol. The similarities extended 
to males as well as females. 
Half body emergence. Figure 6 illustrates the significant dose 
main effect (FB(3,40)=3.04, p<.05). The sex main effect was also 
significant for this variable (FA(l,40)=4.75, p<.05). Females showed an 
average emergence latency of 44.44 sec while for males it was 103.10 sec. 
Post hoc t-tests showed that rats in the 20mg/kg groups emerged 
significantly faster that those in the 5 and lOmg/kg groups. 
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Figure 6 
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Total body emergence. As with the half body emergence measure 
both the sex main effect (FA(l,40)=4.7, p<.05) and the dose main effect 
were significant (FB(3,40)=4.78, p<.01). A similar dose response 
relationship was obtained to the half body emergence measure. This might 
be expected since the measures are not independent. Figure 7 shows the 
relationship between oxprenolol and total body emergence. The 20mg/kg 
dose was associated with a reduction in total body emergence latency 
significantly below that of the saline, 5mg/kg and lOmg/kg groups. All 
other comparisons were non significant. The significant difference 
between the saline and 20mg/kg group agrees with that found by Hughes 
(1981). Hughes noted that both 10 and 20mg/kg oxprenolol significantly 
shortened the emergence latencies of hooded rats in comparison to 
controls. Methodological differences could account for the differing 
results in the lOmg/kg groups. Hughes' subjects were experiencing the 
effects of oxprenolol for the second time, having been injected one week 
previously with the same dose. 
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For the total body emergence measure females showed a mean 





























Oxprenolol dose main effect on total body 
emergence latency 
5 mg/kg 10 mg/kg 
DOSE 
20 mg/kg 
To summarise the results of Experiment Two, significant dose main 
effects occurred for rearing, half body emergence and total body 
emergence measures. Rats treated with 20mg/kg oxprenolol showed 
significantly shorter mean total body emergence times than animals in 
other groups. This could indicate decreased emotionality in the 20mg/kg 
subjects. However, there was no significant support for this interpreta-
tion from walking, grooming, corners or centre measures. 20mg/kg rats had 
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significantly shorter mean half body emergence latencies than the 5 and 
lOmg/kg groups but not the saline group. How this result should be 
interpreted is unclear. 
Drugged animals reared significantly less than saline controls. 
If rearing is inversely related to emotionality (Ader, 1965; Gray, Levine 
and Broadhurst, 1965) this suggests, in contrast to results from the 
total body emergence measure, that oxprenolol increased emotionality. 
Alternatively the rearing results could be interpreted in terms of 
decreased exploratory behaviour (Pare, 1964) or sedation due to 
oxprenolol administration. Once again there was no significant support 
for these interpretations from other measures such as walking and 
emergence latencies. Some validation was obtained from within the 
significant sex-dose interaction effect on transition behaviour. 20mg/kg 
males recorded significantly fewer transitions than saline and 5mg/kg 
males (20mg/kg females showed the opposite tendency, recording 
significantly more transitions than the lOmg/kg group). 
Significant sex main effects were obtained for rearing, half body 
emergence and total body emergence measures. For all these variables 
females showed the higher level of activity. With respect to walking, 





Forty-eight albino rats, randomly derived Wistar strain, 18 males 
(mean age 130 days; range 125-136) and 30 females (mean age 124 days; 
range 117-129) from the Otago Medical School colony were used. These 
animals were reared and maintained under identical conditions to those of 
Experiments One and Two. 
Apparatus 
The same emergence test and open field apparatus described in 
Experiments One and Two were used. 
Procedure 
Procedural details followed those of Experiments One and Two with 
the exception of drug administration. Animals were injected (2cc/kg i.p.) 
with isotonic saline or atenolol (5, 10 or 20mg/kg). 
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RESULTS AND DISCUSSION 
As in Experiments One and Two, 2x4 Analyses of Variance followed 
by t-tests were used to evaluate the data. Results of the statistical 
analyses are summarised in Appendix c. Boli measures were not included 
in the analysis because of high between- and within-group variability. 
Walking. Only the sex main effect was significant (F(l,40)=8.75, 
p<.01). The sex difference was in the expected direction, with females 
exhibiting greater activity than males. 
females was 20.95 and for males was 15.34. 
The mean walking score for 
Rearing. For this variable both the sex main effect (FA(l,40)= 
5.01, p<.05) and the dose main effect were significant (FB(3,40)=5.17, 
p<.01). The dose main effect is shown in Figure 8. Both the 5 and 
lOmg/kg groups showed mean rearing scores significantly greater than the 
saline and 20mg/kg groups. The significant sex difference once again 
showed females exhibiting greater rearing activity than males. The 
average rearing score for females was 31.07, that for males was 22.86. 
Grooming. Neither main effect nor the interaction effect was 
significant. 
Transitions. Only the sex main effect was significant (FA(l,40)= 
22.5, p<.01). The sex differrence was once again in the expected 
direction, with females showing greater activity. The average transition 















Atenolol dose main effect on rearing scores 




Corners. There were no significant effects for this variable. 
Although non significant, there was a trend towards increasing cornering 
behaviour with increasing drug dose. 
Centres. Once again there were no significant effects. Reflecting 
the association of this variable with the previous one (ie. the 
behaviours are mutually exclusive) a trend towards decreasing centering 
behaviour with increasing drug dose was observed (~=19.97 (saline), 22.13 
(Smg/kg), 15.37 (lOmg/kg), and 7.62 (20mg/kg). 
Half body emergence. Figure 9 illustrates the significant inter-
action effect for atenolol (FAB(3,40)=3.47, p<.05). The sex main effect 
was also significant (FA(l,40)=6.49, p<.05). Males showed a mean 
emergence time of 102.3 sec, for females it was 36.64 sec. 
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Differing doses of atenolol significantly affected the half body 
emergence times of males only. The Smg/kg group showed a mean emergence 
time significantly greater than all other groups {p<.05 (saline), p<.05 
(lOmg/kg), p<.01 {20mg/kg)). This increase at the Smg/kg dose is 
inexplicable and suggests that some extraneous variable is affecting the 
group. Since all the animals in this group {N=4) were tested on the 
same day it is possible that some feature of the environment affected 
behaviour, for example a temperature fluctuation. However, a similar 
increase in emergence time is not obvious in the Smg/kg female group, two 
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Total body emergence. Although none of the effects were 
significant trends were similar to those found in the half body emergence 
measure. 
In summary, results of Experiment Three indicated that females 
showed significantly greater activity levels than males for the walking, 
rearing, transitions and half body emergence measures. For rearing the 
dose main effect was also significant. Rats injected with 5 and l0mg/kg 
atenolol gained significantly greater mean rearing scores that those in 
the saline and 20mg/kg groups. Such an inverted U shaped dose response 
curve has no obvious interpretation. One could speculate that at doses 
of 5 and l0mg/kg atenolol either potentiates exploration or general 
activity or decreases emotionality. In contrast, at 20mg/kg the dose 
takes on noxious properties, inhibiting activity or increasing 
emotionality to levels experienced by the saline group. 
The interaction effect was significant for the half body emergence 
measure. Smg/kg males took significantly longer to emerge than males in 
other groups. As previously mentioned, such a result was probably due to 
some unexplained external influence on the subjects in this group. 
Main effects and interaction effects were insignificant for the 
grooming, corners, centres and total body emergence measures. 
CHAPTER FIVE 
GENERAL CONCLUSIONS 
Results for the three drugs propranolol, oxprenolol and atenolol 
showed more differences than similarities. It would seem unlikely, 
therefore, that the blockers used in these experiments exerted their 
effects via the same mechanism of action. Had Experiments One, Two and 
Three produced equivalent results it might have been appropriate to 
conclude that any anxiolytic effects exerted by propranolol (and 
oxprenolol) were peripherally mediated since, although all three drugs 
show peripheral activity, at~nolol shows very little activity within the 
centre! nervous system. Some evidence for a centrally mediated drug 
effect came from the results obtained for female subjects treated with 
propranolol (decreased rearing and walking, increased cornering). These 
results could be interpreted in terms of a drug related decrease in 
exploratory behaviour or a sedation effect, both of which are under 
central nervous control. Alternatively, as previously mentioned, some 
property of the drug itself may have been aversive to the subjects, 
resulting in increased emotionality. If the significant effects on male 
subjects (increased walking, decreased cornering) given propranolol were 
interpreted with an exploratory drive framework it would be possible to 
conclude that, here also, the drug was having its effect on central 
processes. The alternative interpretation of these results is in terms 
of an antianxiety effect, which may or may not include an influence on 
exploratory behaviour. Since the results of this group differed from 
those obtained for subjects treated with atenolol it may be valid to 
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suggest that propranolol's effect was centrally mediated. Such a result 
would be in agreement with the majority of animal research. 
The significant drug related decreases in rearing obtained with 
oxprenolol show similarities to those found in female subjects treated 
with propranolol. As such, there is the possibility that oxprenolol's 
effect was central. Decreased drug-related rearing does not suggest that 
the effect was an anxiolytic one. Such a result is more in keeping with 
a decrease in exploratory drive or sedation. Support for this inter-
pretation comes from the transition scores of males treated with 
oxprenolol. Transition scores decreased with increasing drug dose. 
Alternative conclusions could be drawn from the emergence measures. 
Here, decreased emergence latencies associated with 20mg/kg oxprenolol 
could indicate an antianxiety effect of the drug. 
Results for atenolol were for the most part insignificant, 
although 20mg/kg subjects showed significantly less rearing behaviour 
than either 5 or lOmg/kg rats, but not saline controls. Such a result 
differs from both those obtained from propranolol and oxprenolol and may 
be attributable to an alternative mechanism of action of the drug. 
Sex differences in behaviour were apparent in all three 
experiments. The direction of these differences with respect to activity 
levels was in agreement with past research (Hitchcock, 1925). Females 
exhibited higher activity levels than males. Sex differences in drug 
effects showed less consistency. While female rats treated with 20mg/kg 
propranolol walked significantly less than controls, 20mg/kg males walked 
significantly more. 20mg/kg treated females engaged in significantly 
more cornering behaviour than Smg/kg females. 20mg/kg males cornered 
significantly less than controls. Similarly, females injected with 
20mg/kg oxprenolol recorded significantly more transitions than the 
lOmg/kg groups, while 20mg/kg males had transition scores significantly 
less than Smg/kg and control males. Such differential effects, although 
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not open to obvious interpretation, were not apparent in past 
investigations, the majority of which used male subjects alone. Sex 
differences in reactivity to the S blockers have not been a feature of 
the literature on human subjects either. However, a comparison of 
results may be inappropriate since, as previously noted, variations in 
blocker effects occur across species. The differences could provide a 
focus of future research in order to determine whether they were an 
artefact of this investigation or a true result of drug administration. 
The present investigation used three drug doses and a control 
saline group in each experiment. A greater range of doses may have 
provided more information about dose-response curves. Doses of lOOmg/kg 
and more have been used in the past so conclusions from the current 
research are based on drug concentrations at the lower end of the scale. 
Upon equilibration across the blood-brain barrier more actual drug is 
found within the central nervous system when higher doses are 
administered peripherally. With S blockers such as oxprenolol and 
atenolol greater concentrations could result in a significant effect on 
central S receptors. For example, Noble and Delini-Stula (1976) found 
decreased grooming behaviour over trials with lOOmg/kg oxprenolol 
administered orally to male Wistar rats. In Experiments One, Two and 
Three no drug had a significant effect on grooming. Possibly this was 
because no retesting occurred. Alternatively this may have been because 
doses were not high enough for a centrally-mediated effect on grooming to 
be observed. Future research should therefore look at a wider range of 
doses in order to obtain a clearer picture of dose-response relation-
ships. 
Conclusions from this study are limited by the relationship of the 
variables measured to the underlying concepts of emotionality, 
exploratory behaviour and general activity. It is unlikely, however, 
that more discriminative variables will be developed since the concepts 
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they are measuring can only be inferred, not quantified directly. For 
this reason also it is difficult to compare the emotional effects of the 
S blockers on rats (and mice) to those on humans. It may be unrealistic 
to expect, therefore, that animal research will clarify the clinical 
picture of S blocker action. 
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APPENDICES 
APPENDIX A 
Summaries of Statistical Analyses 
for Experiment One 
Note: * p<.05~ ** p<.01 
t-test comparisons were carried out in order to distinguish 
significant differences in group means. Comparisons were based on 
graphical differences between group mean points along the Y axis 
(ie. those points which were the greatest distance apart were 
compared first). 
Once distances between means yielded insignificant differences no 




ANOVA Summary Table: Walking Measure 
Source of ss df MS F 
Variation 
A (sex) 0 1 0 0 
B (dose) 366.17 3 122.06 1.74 
AB 1171.20 3 390.40 5.56** 
error 2808.19 40 70.20 
Table 2 
ANOVA Summary Table: Rearing Measure 
Source of ss df MS F 
Variation 
A (sex) 481.92 1 481.92 5.67* 
B (dose) 69.63 3 23.21 0.27 
AB 800.24 3 266.75 3.14* 































ANOVA Summary Table: Transitions Measure 
ss df MS 
426.83 1 426.83 
182.92 3 60.97 
2162.89 3 720.96 












ANOVA Summary Table: Corners Measure 
Source of ss df MS F 
Variation 
A (sex) 112. 51 1 112. 51 0.24 
B (dose) 1137.95 3 379.32 0.81 
AB 4524.62 3 1508.21 3.24* 
error 18636.02 40 465.90 
Table 6 
ANOVA Summary Table: Centres Measure 
Source of ss df MS F 
Variation 
A (sex) 4.01 1 4.01 0.10 
B (dose) 69.24 3 23.08 0.59 
AB 284.57 3 94.86 2.44 
error 1556.48 40 38.91 
53 
Table 7 
ANOVA Summary Table: Half Body Emergence Measure 
Source of ss df MS F 
Variation 
A (sex) 4859.05 1 4859.05 0.50 
B (dose) 71737. 42 3 23912.47 2.47 
AB 13592.03 3 4530.68 0.47 
error 387307.14 40 9682.68 
Table 8 
ANOVA Summary Table: Total Body Emergence Measure 
Source of ss df MS F 
Variation 
A (sex) 24248.33 1 24248.33 2.3 
B (dose) 21606.75 3 7202. 25 0.68 
AB 43073.65 3 14357.88 1.36 
error 422242.55 40 10556.06 
Table 9 
Individual Comparisons for Propranolol Dose-Sex 
Interaction Upon Walking Scores 
Comparison 
Male 
Saline vs Smg/kg 
Saline vs l0mg/kg 
Saline vs 20mg/kg 
Female 
Saline vs l0mg/kg 
Saline vs 20mg/kg 

















Individual Comparisons for Propranolol Dose-Sex 
Interaction Upon Rearing Scores 
Comparison 
Male 
Saline vs 20mg/kg 
Female 
Saline vs 5mg/kg 
Saline VS 20mg/kg 
5mg/kg vs 20mg/kg 















Individual Comparisons for Propranolol Dose-Sex 
Interaction Upon Corner Scores 
Comparison 
Male 
Saline vs 5mg/kg 
Saline vs lOmg/kg 
Saline vs 20mg/kg 
l0mg/kg vs 20mg.kg 
Female 
Saline vs 20mg/kg 
5rng/kg vs 20mg/kg 



















Summaries of Statistical Analyses 
for Experiment Two 
Note: * p<.05; ** p<.01 
The procedure for selection oft-test comparisons followed that 




ANOVA Summary Table: Walking Measure 
Source of ss df MS F 
Variation 
A (sex) 36.21 1 36.21 0.57 
B (dose) 198.79 3 66.26 1.04 
AB 74.53 3 24.84 0.39 
error 2547.36 40 63.68 
Table 13 
ANOVA Summary Table: Rearing Measure 
Source of ss df MS F 
Variation 
A (sex) 481.25 l 481.25 5.99* 
B (dose) 1051. 73 3 350.58 4.36** 
AB 167.49 3 55.83 0.69 































ANOVA Summary Table: Transitions Measure 
ss df MS 
656.20 1 656.20 
947.40 3 315.80 
1443.24 3 481.08 








































ANOVA Summary Table: Centres Measure 
ss df MS 
13.81 1 13.81 
46.84 3 15.61 
63.78 3 21.26 












ANOVA Summary Table: Half Body Emergence Measure 
Source of ss df MS F 
Variation 
A (sex) 38335.97 1 38335.97 4.75* 
B (dose) 73626.66 3 24542.22 3.04* 
AB 43280.57 3 14426.86 1.79 
error 323050.72 40 8076.27 
Table 19 
ANOVA Summary Table: Total Body Emergence Measure 
Source of ss df MS F 
Variation 
A (sex) 56093.46 1 56093.46 4.70* 
B (dose) 170656.33 3 56885.44 4.78** 
AB 23928.50 3 7976.17 0.67 
error 476172.14 40 11904. 30 
Table 20 
Individual Comparisons for Oxprenolol Dose Main 



















Individual Comparisons for Oxprenolol Dose-Sex 






5mg/kg vs lOmg/kg 

















Individual Comparisons for Oxprenolol Dose Main 











Individual Comparisons for Oxprenolol Dose Main 
Effect Total Body Emergence Scores 
Comparison df 
Saline vs Smg/kg 40 
Saline vs l0mg/kg 40 
Saline vs 20mg/kg 40 
Smg/kg vs l0mg/kg 40 
Smg/kg vs 20mg/kg 40 















Summaries of Statistical Analyses 
for Experiment Three 
Note: * p<.05; ** p<.01 
The procedure for selection oft-test comparisons followed that 




ANOVA Summary Table: Walking Measure 
Source of ss df MS F 
Variation 
A {sex) 351.19 1 351.19 8.75** 
B {dose) 257.39 3 85.80 2.14 
AB 220.46 3 73.49 1.83 
error 1604.90 40 40.12 
Table 25 
ANOVA Summary Table: Rearing Measure 
Source of ss df MS F 
Variation 
A (sex) 749.94 1 749.94 5.01* 
B (dose) 2324.80 3 774. 94 5.17** 
AB 29.24 3 9.75 0.07 
error 5986.79 40 149.67 
66 
Table 26 
ANOVA Summary Table: Grooming Measure 
Source of ss df MS F 
Variation 
A (sex) 3.12 1 3.12 0.03 
B (dose) 175.68 3 58.56 0.53 
AB 186.04 3 62.01 0.56 
error 4442.87 40 111.07 
Table 27 
ANOVA Summary Table: Transitions Measure 
Source of ss df MS F 
Variation 
A (sex) 7610.51 1 7610. 51 22.5** 
B (dose) 1912.91 3 637.64 1.89 
AB 1332.23 3 444.08 1.31 
error 13526.67 40 338.17 
67 
Table 28 
ANOVA Summary Table: Corners Measure 
Source of ss df MS F 
Variation 
A (sex) 275.49 1 275.49 0.81 
B (dose) 1601.76 3 533.92 1.57 
AB 223.02 3 74.34 0.22 
error 13567.17 40 339.18 
Table 29 
ANOVA Summary Table: Centres Measure 
Source of ss df MS F 
Variation 
A (sex) 0.45 1 0.45 0.88 
B (dose) 344.39 3 114. 80 2.24 
AB 14.15 3 4.72 0.09 
error 2051. 93 40 51.30 
68 
Table 30 
ANOVA Summary Table: Half Body Emergence Measure 
Source of 88 df MS F 
Variation 
A (sex) 48034.45 1 48034.45 6.49* 
B (dose) 58486.89 3 19495.63 2.64 
AB 77012. 99 3 25671.00 3.47* 
error 295937.28 40 7398.43 
Table 31 
ANOVA Summary Table: Total Body Emergence Measure 
Source of ss df MS F 
Variation 
A (sex) 39140.67 1 39140.67 2.92 
B (dose) 77307.14 3 25769.05 1.92 
AB 83120.55 3 27706. 85 2.07 
error 535496. 42 40 13387.41 
Table 32 
Individual Comparisons for Atenolol Dose Main 













Individual Comparisons for Atenolol Dose-Sex 
Interaction Effect on Half Body Emergence Scores 
Comparison df 
Male 
Saline vs 5mg/kg 40 
Saline vs l0mg/kg 40 
Saline vs 20mg/kg 40 
5mg/kg vs l0mg/kg 40 
5mg/kg vs 20mg/kg 40 
Female 
5mg/kg vs l0mg/kg 40 
69 
t 
2.35* 
2.24* 
1.01 
3.37** 
3.25** 
t 
2.33* 
0.32 
1.33 
2.63* 
3.47** 
0.67 
